Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Friday, June 2, 2017

Teva’s Migraine Candidate TEV-48125 Positive in Phase III

http://ift.tt/1JFNLm7

finance44.jpg

Teva Pharmaceutical Industries Limited TEVA announced positive top line results from a phase III study HALO evaluating its pipeline candidate fremanezumab TEV 48125 for prevention of chronic migraine CM The study met both its primary and secondary end points The company will

June 02, 2017 at 06:52AM

http://ift.tt/2qGPO1A

from

http://ift.tt/2qGPO1A


Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)